What Researchers Did
Researchers reviewed existing theory and evidence regarding the potential role of hyperbaric oxygen therapy in treating sternal wound infections.
What They Found
The review found that sternal ischemia may significantly contribute to the development of sternal wound infections, a condition potentially exacerbated by internal thoracic artery harvest. While the theoretical mechanisms for hyperbaric oxygen therapy (HBOT) in treating these infections appear plausible, the current clinical evidence supporting its widespread use is limited.
What This Means for Canadian Patients
For Canadian patients experiencing sternal wound infections, this review suggests that hyperbaric oxygen therapy (HBOT) presents a theoretically plausible treatment option. However, patients should be aware that current clinical evidence supporting HBOT for this specific condition is still limited, and they should discuss all available treatment approaches with their medical team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This review is limited by the scarcity of robust clinical evidence currently available to definitively support the widespread use of hyperbaric oxygen therapy for sternal wound infections.